Hospice News October 26, 2024
Executives from UnitedHealth Group (NYSE: UNH) and Amedisys (NASDAQ: AMED) reportedly will meet with U.S. Justice Department officials in an effort to seal their pending deal.
Amedisys has indicated that it expects the deal to close in Q4. However, the Justice Department (DOJ) has been making inquiries into the transaction and reportedly has been considering a lawsuit to block it, due to potential antitrust concerns. To date, neither Amedisys nor UnitedHealth Group have been accused of any wrongdoing.
Bloomberg first reported on the DOJ meeting, which might begin on Monday, according to sources “familiar with the matter.” The meeting will include Jonathan Kanter, assistant attorney general for the DOJ’s Antitrust Division, Bloomberg reported.
The UnitedHealth Group subsidiary Optum in June...
Today's Sponsors
Today's Sponsor